Search Results 41-50 of 6284 for younkin

  1. Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

  2. A Study of Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy - Mayo Clinic

    Drugs used in chemotherapy, such as daunorubicin and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by ...

  3. Young J. Juhn, M.D., M.P.H.

    Young J. Juhn, M.D., a Mayo Clinic pediatric medicine and clinical informatics specialist, researches asthma and health equity using artificial intelligence ...

  4. Hypofractionated Radiation Therapy in Treating Participants With Prostate Cancer High-Risk Features Following Radical Prostatectomy - Mayo Clinic

    About this study. This phase II trial studies how well hypofractionated radiation therapy works in treating participants with prostate cancer high-risk ...

  5. Publications - Winston Tan, M.D. - Mayo Clinic

    Cancer and Clinical Oncology. 01/2013; 2(1):1-7. Tan WW, Heckman MG, Vishnu P, Crook JE, Younkin LH, Covil ...

  6. A Study of DNA/RNA Sequencing Results on the Clinical Management of Patients with Advanced Malignancies

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  8. A Study to Evaluate Web-Based Physical Activity Intervention in Children and Adolescents with Newly Diagnosed Acute Lymphoblastic Leukemia in First Remission - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study to Evaluate Azacitidine Plus Venetoclax Induction Chemotherapy To Treat Acute Myeloid Leukemia Patients for T-cell Directed Immunotherapy - Mayo Clinic

    A Study to Evaluate Azacitidine Plus Venetoclax Induction Chemotherapy To Treat Acute Myeloid Leukemia Patients for T-cell Directed Immunotherapy.

  10. International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) - Mayo Clinic

    About this study. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...